US74006W2070 - PRAX (XNAS)
Praxis Precision Medicines, Inc. - Common Stock Aktie
63,02 USD
Aktuelle Kurse von Praxis Precision Medicines, Inc. - Common Stock
Börse | Ticker | Währung | Letzter Umsatz | Kurs | Tagesveränderung | Tagesveränderung % |
---|---|---|---|---|---|---|
NASDAQ |
PRAX
|
USD
|
19.09.2024 22:37
|
63,02 USD
| 59,38 USD | 6,13 % |
Performance
Tag | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
0,00 % | 5,24 % | 21,66 % | 67,21 % | 17,25 % | 183,87 % | -84,89 % |
Firmenprofil zu Praxis Precision Medicines, Inc. - Common Stock Aktie
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of major depressive disorder and perimenopausal depression; and PRAX-944, a selective small molecule inhibitor of T-type calcium channels, which is in Phase IIa clinical trial for the treatment of essential tremor. The company is also developing PRAX-562, a persistent sodium current blocker that is in Phase I clinical trial to treat severe pediatric epilepsy and adult cephalgia; PRAX-222, an antisense oligonucleotide (ASO) for patients with gain-of-function (GOF) SCN2A epilepsy; and KCNT1 program for the treatment of KCNT1 GOF epilepsy. It has a cooperation and license agreement with RogCon Inc.; a license agreement with Purdue Neuroscience Company; a research collaboration, option, and license agreement with Ionis Pharmaceuticals, Inc.; and collaboration with The Florey Institute to develop three novel ASOs. The company was incorporated in 2015 and is based in Boston, Massachusetts.
Unternehmensdaten zur Praxis Precision Medicines, Inc. - Common Stock Aktie
Name Praxis Precision Medicines, Inc. - Common Stock
Firma Praxis Precision Medicines, Inc.
Symbol PRAX
Website https://www.praxismedicines.com
Heimatbörse
NASDAQ
ISIN US74006W2070
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Mr. Marcio Silva De'Souza M.B.A.
Marktkapitalisierung 959 Mio
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,1 T
Adresse 99 High Street, 02110 Boston
IPO Datum 2020-10-16
Ticker Symbole
Name | Symbol |
---|---|
NASDAQ | PRAX |
Weitere Aktien
Investoren die Praxis Precision Medicines, Inc. - Common Stock halten haben auch folgende Aktien im Depot:
Die Finanzplattform goSPATZ trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
All rights reserved © LCP GmbH 2024